Endogena Therapeutics AG
We develop first-in-class endogenous regenerative medicines
ENDOGENA THERAPEUTICS
is a preclinical-stage biotech company that discovers and develops first-in-class endogenous regenerative medicines to repair and regenerate tissues and organs. Our approach has the potential of a paradigm shift to treat degenerative conditions related to ageing and genetic disorders.
Our projects are constantly progressing and we are planning entering clinical trials this year.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
26.10.2023
Endogena to bring second drug candidate into clinical trials (startupticker.ch)
18.07.2022
Endogena starts clinical trials for regenerative treatment for blindness (startupticker.ch)
20.05.2021
Endogena Therapeutics receives FDA Orphan Drug designation (startupticker.ch)
No milestones
No Jobs
No videos and documents
No Awards
Endogena Therapeutics AG
We develop first-in-class endogenous regenerative medicines
Website:
endogena.com/index.html
Headquarter:
Foundation Date:
October 2020
Technology:
- Biotech
Sectors:
- Biotech